Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1282 |
---|---|
Product Name | Anti-Human CFD Recombinant Antibody |
Molecular Name | Lampalizumab |
Alias | Anti-CFD Recombinant Antibody, Research Grade Lampalizumab |
CAS Number | 1278466-20-8 |
Target | CFD[Homo sapiens] |
Isotype | Fab-G1 Kappa |
Clonity | Monoclonal |
Host | Mouse |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | ELISA, IP, FCM, FuncS, Neut, IF, Stim |
Buffer | PBS, pH7.5 |
Background | Lampalizumab (INN) is an antigen-binding fragment of a humanized monoclonal antibody that binds to complement factor D, it was developed as a potential treatment of geographic atrophy (atrophy of the retinal cells, retinal pigment epithelium, and choriocapillaris) secondary to age-related macular degeneration. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |